The tweet was deleted by the author.
But we saved everything 🙂.
Pacific Biosciences of California unveils new research using its PacBio HiFi technology to map hundreds of structural variants, novel isoforms, and critical fusions in cancer genomics.
The platform aims to predict patient survival and guide treatment decisions, capturing complex genetic insights in one comprehensive workflow. This innovation has the potential to transform cancer research and clinical applications.
View post on X Loading...
Pacific Biosciences’ expanding suite of genomic solutions continues to drive advancements in precision medicine, building on its earlier introduction of automatic epigenetic detection in HiFi sequencing for enhanced data accuracy. Recent developments not only map structural variants in cancer but also reflect progress in integrating comprehensive epigenetic sequencing, as highlighted by the company’s move to enable automatic detection of 5mC and 6mA in its workflows.